نتائج البحث - "Alberto, Papi"

المساهمون: National Jewish Health, Fundación Cidea Allergy and Respiratory Research Unit, University of Oxford [Oxford], Università degli Studi di Ferrara (UniFE), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), German Centre for Lung Research, Partenaires INRAE, University of Missouri [Kansas City] (UMKC), University of Missouri System, Kindai University, Frankston Hospital, parent, Universitat Autònoma de Barcelona (UAB), Ajou University, University of Toronto, Sanofi [Bridgewater, NJ, USA], Regeneron Pharmaceuticals [Tarrytown], Sanofi Aventis R&D [Chilly-Mazarin]

المصدر: The Lancet Respiratory Medicine
The Lancet Respiratory Medicine, Elsevier, 2021, ⟨10.1016/S2213-2600(21)00322-2⟩

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Adult, Male, medicine.medical_specialty, Adolescent, [SDV]Life Sciences [q-bio], Socio-culturale, Moderate-to-severe asthma, Placebo, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Double-Blind Method, Internal medicine, dupilumab, medicine, Clinical endpoint, Humans, Anti-Asthmatic Agents, Adverse effect, non-oral-corticosteroids, Child, 030304 developmental biology, Asthma, Aged, Aged, 80 and over, 0303 health sciences, business.industry, exacerbation rate, Middle Aged, medicine.disease, Dupilumab, 3. Good health, Clinical trial, Treatment Outcome, 030228 respiratory system, Asthma Control Questionnaire, Moderate-to-severe asthma, dupilumab, non-oral-corticosteroids, exacerbation rate, Quality of Life, Bronchitis, Female, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::828a5b08dc17d4200d31d0d5511c4a7fTest
https://hal.archives-ouvertes.fr/hal-03363008Test

7

Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease

المؤلفون: Elisabetta Tonet, Rita Pavasini, Gianluca Campo, Simone Biscaglia, Alberto Papi, Cristina Balla, Elisa Maietti, Eleonora Gaudenzi, Andrea Fiorencis, Roberto Ferrari, Marco Contoli

المصدر: COPD: Journal of Chronic Obstructive Pulmonary Disease. 16:284-291

مصطلحات موضوعية: Male, Pulmonary and Respiratory Medicine, Acute coronary syndrome, medicine.medical_specialty, Heart Ventricles, undiagnosed COPD, Pulmonary disease, Disease, right ventricle, NO, Strain, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Forced Expiratory Volume, Internal medicine, medicine, Humans, In patient, Prospective Studies, 030212 general & internal medicine, Acute Coronary Syndrome, Aged, COPD, Strain, acute coronary syndrome, fractional area change, right ventricle, undiagnosed COPD, business.industry, fractional area change, Middle Aged, medicine.disease, respiratory tract diseases, medicine.anatomical_structure, 030228 respiratory system, Echocardiography, Ventricle, Concomitant, Ventricular Function, Right, Cardiology, Female, Ischemic heart, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a7e662647b5c7485e5a1f18e14a0b62Test
https://doi.org/10.1080/15412555.2019.1645105Test

8

Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study

المؤلفون: Helgo Magnussen, Sarah Lucas, Therese Lapperre, Jennifer K. Quint, Ronald J. Dandurand, Nicolas Roche, Alberto Papi, David Price, Marc Miravitlles, the Respiratory Effectiveness Group (REG)

المساهمون: Institut Català de la Salut, [Magnussen H] Pulmonary Research Institute at Lung Clinic Grosshansdorf, Airway Research Center North, Member of the German Center of Lung Research, Grosshansdorf, Germany. [Lucas S] Respiratory Efectiveness Group, Ely, UK. [Lapperre T] Department of Respiratory Medicine, Antwerp University Hospital, Edegem, Denmark. Laboratory of Experimental Medicine and Paediatrics, University of Antwerp, Wilrijk, UK. [Quint JK] Laboratory of Experimental Medicine and Paediatrics, University of Antwerp, Wilrijk, UK. [Dandurand RJ] CIUSSS de L’Ouest de L’Île de Montréal, Montreal Chest Institute, Meakins Christie Laboratories, Oscillometry Unit and Centre for Innovative Medicine, McGill University Health Centre and Research Institute, Montreal, QC, Canada. [Miravitlles M] Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Respiratory Effectiveness Group (REG)

المصدر: Scientia
Respiratory research
Respiratory Research
Respiratory Research, Vol 22, Iss 1, Pp 1-14 (2021)

مصطلحات موضوعية: Male, Exacerbation, Respiratory System, Effectiveness, Pulmons - Malalties obstructives - Tractament, Rate ratio, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Adrenal Cortex Hormones, 030212 general & internal medicine, 1102 Cardiorespiratory Medicine and Haematology, Aged, 80 and over, COPD, education.field_of_study, Inhaled corticosteroids, Pharmacoepidemiology, Middle Aged, Bronchodilator Agents, enfermedades respiratorias::enfermedades pulmonares::enfermedades pulmonares obstructivas::enfermedad pulmonar obstructiva crónica [ENFERMEDADES], Treatment Outcome, Withdrawal, Female, COPD, effectiveness, inhaled corticosteroids, real life, withdrawal, medicine.medical_specialty, Population, Real life, Socio-culturale, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Respiratory Effectiveness Group (REG), 03 medical and health sciences, Safety-Based Drug Withdrawals, Internal medicine, Pharmacovigilance, Administration, Inhalation, medicine, Humans, education, Aged, lcsh:RC705-779, Respiratory Tract Diseases::Lung Diseases::Lung Diseases, Obstructive::Pulmonary Disease, Chronic Obstructive [DISEASES], business.industry, Research, diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], 1103 Clinical Sciences, lcsh:Diseases of the respiratory system, medicine.disease, Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Confidence interval, United Kingdom, Discontinuation, 030228 respiratory system, Avaluació de resultats (Assistència sanitària), Human medicine, business